Skip to content
  1. Home
  2. Latest news
  3. Innovation
  4. Sutures: The iconic Johnson & Johnson invention that revolutionized medicine
An infographic with fun facts about the history of Johnson & Johnson’s surgical sutures

Sutures: The iconic Johnson & Johnson invention that revolutionized medicine

To commemorate the month that the company first listed sutures in its 1887 inventory book, we’re unspooling fun facts about the ubiquitous medical innovation.

A common thread in Johnson & Johnson’s storied century-plus history is its commitment to innovation in healthcare. One of its most revolutionary inventions? The mass production of sterile surgical sutures, which forever changed the field of medicine, and helped improve the outcomes of patients going into the operating room for the better.

The revolutionary product first appeared in a Johnson & Johnson cash book (a business ledger listing inventory and expenditures) as “ligatures” in January 1887. Since then, suture innovation has continued at the company, leading to a long string of follow-up products that are changing the surgery game in their own right.

This infographic spins the full tale of the great history—and exciting future—of those signature sutures.

A graphic of surgical sutures

When you’ve been innovating for over 135 years …

Johnson & Johnson has a virtual museum where you can learn more fun facts about its rich history.
Johnson & Johnson's new museum at its world headquarters in New Jersey
© Albert Vecerka/Esto. All rights reserved.

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.